The Arizona Biomedical Research Centre (ABRC) invites you to conduct peer reviews of research grant applications on behalf of the Arizona Department of Health Services. The ABRC relies on subject matter experts (SMEs) from around the globe to evaluate the merits of the grant applications, and solicits their participation as needed. Continue reading
Author Archive: AZBio
Gilead Signs Royalty-Free Voluntary Licensing Agreements with Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries
- License for Companies to Manufacture and Supply High-Quality, Low-Cost Versions of Lenacapavir for 120 Primarily Low- and Lower-Middle Income Countries –
- Gilead Plans to PriceProduct at No Profit to the Company and Supply Lenacapavir Until Generic Manufacturers Fully Support Demand –
- Agreements Also Cover Lenacapavir for HIV Treatment in Heavily Treatment-Experienced Adults with Multi-Drug Resistant HIV –
ASU researchers use AI to help people see more clearly
A serious, irreversible eye disease known as myopic maculopathy is on the rise. Yalin Wang, a professor of computer science and engineering in the School of Computing and Augmented Intelligence at ASU, is leading a team to find solutions. Continue reading
Calviri initiates trial of therapeutic vaccine for early-stage hemangiosarcoma cancer in dogs
First subject vaccinated with investigational vaccine for early-stage hemangiosarcoma in combination with standard treatment
Hemangiosarcoma, or HSA, is a common and uniformly fatal cancer in dogs, with particularly high incidence in some popular breeds.Continue reading
Application for the Class of 2025 Termeer Fellowship is now open!
This is a unique opportunity for first-time biotech and life science CEOs to join an inclusive and empowering community dedicated to developing the next generation of leaders who are shaping the future of healthcare.Continue reading
Do You Have a Session Idea for BIO 2025?
The submission deadline is October 17, 2024.
Download the 2025 Submission Guide.
Individuals whose proposals have been selected will be notified mid-January 2025.Continue reading
NIH Launches Redesigned Grants and Funding Website
NIH launched the new NIH Grants and Funding website in September. Designed with the needs of the extramural research community in mind, the new site is intended to enhance your journey through the NIH grants process with a modernized interface and powerful features to make finding critical information easier than ever.
A key change involves a redesign of the NIH Guide for Grants and Contracts and related funding information. The new tools reduce reliance on activity codes and other NIH jargon to help you explore opportunities for funding in a more intuitive way.Continue reading
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults
COBENFY represents the first new pharmacological approach to treat schizophrenia in decades, with a mechanism of action distinct from current therapies
Approval is supported by data from the EMERGENT clinical program demonstrating statistically significant reductions of schizophrenia symptoms
The safety and tolerability profile of COBENFY has been established across acute and long-term trials in schizophrenia
Continue reading
Nectero Medical Recognized as a 2024 AZBio Fast Lane Award Winner
TEMPE, Ariz., Sept. 24, 2024 (GLOBE NEWSWIRE) — Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced today that it received a 2024 AZBio™ Fast Lane Award from the Arizona Bioindustry Association (AZBio). Each year a select group of Arizona-based life science companies are recognized for the progress they are making to develop and deliver health innovations. Nectero Medical accepted the award at the 20th Annual AZBio Awards Dinner held on Wednesday, September 18th at the Phoenix Convention Center as part of Arizona Bioscience Week, which is presented by AZBio and the Arizona Commerce Authority.Continue reading
